Viewing Study NCT06004856


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2025-12-25 @ 9:16 PM
Study NCT ID: NCT06004856
Status: RECRUITING
Last Update Posted: 2024-05-13
First Post: 2023-08-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module